AngioDynamics | ANGO - Operating Expenses


AngioDynamics reported $81.95M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 140.72M 2.71M Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
ICU Medical USD 514.62M 4.48M Dec/2025
Inogen USD 49.14M 665K Sep/2024
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Smiths GBP 749M 617M Jun/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025